Boothbay Fund Management, LLC Finch Therapeutics Group, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.75 - $51.3 $30,339 - $889,388	-17,337 Reduced 42.06%	23,887 $40,000
Q2 2022 Aug 15, 2022	BUY	$1.91 - $5.11 $17,554 - $46,966	9,191 Added 28.69%	41,224 $117,000
Q3 2021 Nov 15, 2021	SELL	$12.2 - $16.75 $42,907 - $58,909	-3,517 Reduced 9.89%	32,033 $416,000
Q2 2021 Aug 16, 2021	BUY	$12.03 - $17.51 $216,179 - $314,654	17,970 Added 102.22%	35,550 $500,000
Q1 2021 May 17, 2021	BUY	$15.54 - $21.32 $273,193 - $374,805	17,580 New	17,580 $284,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $575M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.